Issue 29
Get instant access to latest e-book

latest news


Jan 2018

AvantGen and Tanabe Research Laboratories Expand Collaboration for Therapeutic Antibody Discovery

AvantGen Inc a privatelyheld antibody discovery and optimization service provider today announced the successful completion of a first cancer therapeutic antibody discovery program and initiation of a second program for Tanabe Research Laboratories USA Inc TRL Under the terms of the collaboration AvantGen is responsible…


Jan 2018

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

Pharmaceutical Product Development LLC PPD a leading global contract research organization CRO and Quotient Sciences Quotient a drug development services organization today announced a new collaboration to accelerate pediatric drug development The partnership leverages PPDs pediatric clinical trial experience regulatory knowledge and site and pediatric…


Jan 2018

Grünenthal and Mundipharma Enter Commercial Partnership in China

Grnenthal and Mundipharma announced today that they have entered into a License and Distribution Agreement Under its terms Mundipharma will market and distribute Grnenthals Tramal tramadol in China from May Developed by Grnenthal Tramal is a wellestablished analgesic for the treatment of moderate to severe…

press releases


Jan 2018

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval in Canada

Innovus Pharmaceuticals Inc an emerging commercialstage pharmaceutical company that delivers safe innovative and effective overthecounter medicine and consumer care products to improve mens and womens health and respiratory diseases today…


Jan 2018

Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies

Tenax Therapeutics Inc announced plans to advance the development of levosimendan for the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction PHHFpEF PHHFpEF is a common…


Jan 2018

China FDA Approves New Once-Weekly Bydureon® to Improve Glycemic Control in Patients with Type-2 Diabetes

Sbio Inc announced that Chinas first Glucagonlike peptide GLP receptor agonist weekly preparation Bydureon generic name Exenatide Microsphere for injection has been formally approved by China Food and Drug Administration…

Events


Jan 2018

7th Trial Master File Summit

ExL Events
Hyatt Regency Grand Cypress


Jan 2018


  • 1

    Mesoporous Silica Nanoparticles

    Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medic..
  • 6

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Blood-Brain Barrier and CNS Drug Delivery

    Introduction The idea of Blood Brain Barrier BBB dates back to more than years ago when Paul Erlich observed that by intravenous injection of certain dyes all organs of the animal body were stained except the brain and the spinal cord The densely packed brain endothelial cells are the main part of BBB which…

  • Techno Trends

    First Digital Pill Tracks Patients Medication

    Abilify MyCite the first digital pill with a sensor digitally tracks if patients have taken their medication Abilify MyCite also gets an approval from the US Food and Drug Administration FDA This first digital pill is fitted with a digital ingestion tracking system and has an ingestible sensor embedded in the pill that records that the medication was taken The…

Editorial Section

  • Strategy


    As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to…

  • Research development

    Knowing vs Hunting for Targets

    Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages…

  • Clinical Trials

    Use of Real World Evidence

    Real World Evidence RWE can be used to inform decisions throughout the life cycle of a drug from development through postapproval Across Asia many countries have begun incorporating real world evidence and while some are fast adopters in terms of…

  • Manufacturing

    Cultural Excellence as the Foundation

    In pharmaceutical companies it is universally understood that a robust Pharmaceutical Quality System PQS provides key elements of assurance and oversight for pharmaceutical manufacturing and quality control laboratory processes However despite recent advances in the…

  • Expert Talk

    Pushing the Limits of Temperature Control

    Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…